...
首页> 外文期刊>International Journal of Epidemiology: Official Journal of the International Epidemiological Association >Commentary: Professor Harry Keen, clinician, epidemiologist, diabetologist, basic scientist and defender of the UK national health service
【24h】

Commentary: Professor Harry Keen, clinician, epidemiologist, diabetologist, basic scientist and defender of the UK national health service

机译:评论:哈里·基恩教授,临床医生,流行病学家,糖尿病学家,英国国家卫生服务的基本科学家和捍卫者

获取原文
获取原文并翻译 | 示例
           

摘要

Harry Keen is arguably the grandfather of diabetes epidemiology, establishing himself at a time when neither specialty was regarded as either interesting or important. He was born in 1925 and qualified in medicine from St Mary's Hospital Medical School in 1948, shortly before the inauguration of the National Health Service, for which he acquired and retained a strong loyalty. After house jobs and National Service, he embarked on his formative years at St Mary's under Professor George Pickering, who remained a strong influence. Harry began clinical research at King's College Hospital, where Pickering had arranged for him to study hypertension in diabetes in the clinic headed by R.D. Lawrence, the second of Harry's mentors. In 1960-61 he spent a fruitful year with James B. Field in the National Institutes of Health, where he was introduced to the fascinations of laboratory research, including bio-assays for insulin and preliminary attempts to isolate islets of Langerhans. He returned to London to join the Department of Experimental Medicine under Professor John Butterfield. Here he was introduced to epidemiology via the planning and execution of the pioneering Bedford Study, later to be followed by participation in the Whitehall Study (now Whitehall 1) originated by Donald Reid and Geoffrey Rose. These studies provided, inter alia, much valuable information about the relations between cardiovascular disease, diabetes and glucose intolerance. The prospective elements of these studies provided much of the data which led to a new definition and classification of diabetes. Indeed, Harry chaired the World Health Organization (WHO) Expert Committee which pronounced on these matters in 1980 and also the WHO Study Group which modified the original proposals in 1985. Largely due to his initiative, a further involvement with WHO led to the Multinational Study of Vascular Disease in Diabetes, a notable example of international scientific collaboration.
机译:哈里·基恩(Harry Keen)可以说是糖尿病流行病学的祖父,他的建立是在这两个专业都不被认为既有趣又重要的时候。他出生于1925年,并于1948年在国家卫生局就职前不久获得圣玛丽医院医学院的医学资格,为此他获得并保持了很强的忠诚度。在从事家庭工作和国民服务之后,他在乔治·皮克林(George Pickering)教授的带领下,在圣玛丽(St Mary's)开始了自己的成长生涯,而他仍然具有很强的影响力。哈里开始在国王学院医院进行临床研究,皮克林安排他在哈里的第二任导师劳伦斯(R.D. Lawrence)领导的诊所里研究糖尿病的高血压。在1960-61年间,他在美国国立卫生研究院(National Institutes of Health)的James B. Field工作了富有成果的一年,在那里他被引诱到了实验室研究的魅力中,包括胰岛素的生物测定以及分离兰格罕氏胰岛的初步尝试。他回到伦敦,加入约翰·巴特菲尔德(John Butterfield)教授的实验医学系。在这里,他通过规划和执行具有开创性的贝德福德研究(Bedford Study)进行了流行病学介绍,随后又参加了由唐纳德·里德(Donald Reid)和杰弗里·罗斯(Geoffrey Rose)发起的白厅研究(现为白厅1号)。这些研究尤其提供了关于心血管疾病,糖尿病和葡萄糖耐受不良之间关系的许多有价值的信息。这些研究的前瞻性要素提供了许多数据,从而导致了糖尿病的新定义和分类。确实,哈里主持了1980年就这些问题发表声明的世界卫生组织(WHO)专家委员会,以及1985年修改原始提案的WHO研究小组。很大程度上是由于他的倡议,进一步参与WHO导致了多国研究。 《糖尿病血管疾病》,这是国际科学合作的一个著名例子。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号